The effect of taurolidine on human blood cells

The effect of taurolidine on human blood cells - The effect of taurolidine on human blood cells

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50878

Enrollment

Registered

2021-07-22

Start date

2021-08-20

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bloodstream infection bloodstream infection Catheter-related bloodstream infection

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers

Exclusion criteria

Exclusion criteria: Age under 18 year

Design outcomes

Primary

Measure	Time frame
To investigate the effects of taurolidine on human blood cells by identification of gene expression, protein production and immune response.	—

Countries

Netherlands

Outcome results